Brief: Biogen To Buy Apellis For $5.6 Billion To Boost Kidney Franchise - Bloomberg News
31/03/2026 11:53
March 31 (Reuters) - BIOGEN TO BUY APELLIS FOR $5.6 BILLION TO BOOST KIDNEY FRANCHISE - BLOOMBERG NEWS BIOGEN WILL PAY $41 A SHARE FOR APELLIS- BLOOMBERG NEWS Source text: https://tinyurl.com/3yvcd6bn ((Reuters.Briefs@thomsonreuters.com;))